| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 7539 |
| 1 | RANITIDINE HYDROCHLORIDE | 2321 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 648 |
| 3 | OMEPRAZOLE MAGNESIUM | 523 |
| 4 | LANSOPRAZOLE | 389 |
| 5 | OMEPRAZOLE | 286 |
| 6 | PANTOPRAZOLE SODIUM | 258 |
| 7 | PANTOPRAZOLE | 229 |
| 8 | ASPIRIN | 227 |
| 9 | ASPIRIN 325 MG | 221 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANITIDINE HYDROCHLORIDE | 2321 | 0.0428 |
| 1 | RANITIDINE | 7539 | 0.0381 |
| 2 | CIMETIDINE HYDROCHLORIDE | 2 | 0.0125 |
| 3 | OMEPRAZOLE, SODIUM BICARBONATE | 9 | 0.0094 |
| 4 | SODIUM IODIDE I 123 | 7 | 0.0074 |
| 5 | SODIUM IODIDE I 131 | 7 | 0.0073 |
| 6 | MEXILETINE HYDROCHLORIDE | 3 | 0.0071 |
| 7 | DAPRODUSTAT | 14 | 0.0070 |
| 8 | TAFASITAMAB-CXIX | 6 | 0.0066 |
| 9 | ALOGLIPTIN | 19 | 0.0056 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 619 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 537 |
| 2 | Corticosteroid [EPC] | 459 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 405 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 261 |
| 5 | Benzodiazepine [EPC] | 236 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 230 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 221 |
| 8 | Loop Diuretic [EPC] | 219 |
| 9 | Factor Xa Inhibitor [EPC] | 206 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 17 | 0.0247 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 15 | 0.0066 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 12 | 0.0058 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 7 | 0.0046 |
| 4 | Provitamin D2 Compound [EPC] | 118 | 0.0040 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 7 | 0.0034 |
| 6 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 18 | 0.0028 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 15 | 0.0026 |
| 9 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |